{"id":"https://openalex.org/W2218436155","doi":"https://doi.org/10.2174/1389200216666151001120831","title":"Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection","display_name":"Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection","alternate_titles":[],"publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2218436155","doi":"https://doi.org/10.2174/1389200216666151001120831","mag":"2218436155","pmid":"https://pubmed.ncbi.nlm.nih.gov/26424177"},"language":"en","primary_location":{"id":"doi:10.2174/1389200216666151001120831","doi":"https://doi.org/10.2174/1389200216666151001120831","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389200216666151001120831","pdf_url":null,"source":{"id":"https://openalex.org/S195680726","display_name":"Current Drug Metabolism","issn_l":"1389-2002","issn":["1389-2002","1875-5453"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2218436155"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087619447","display_name":"Francesco Semeraro","orcid":"https://orcid.org/0000-0002-2275-4917","observed_orcids":["https://orcid.org/0000-0002-2275-4917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Semeraro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045153247","display_name":"Francesco Morescalchi","orcid":"https://orcid.org/0000-0002-3553-0736","observed_orcids":["https://orcid.org/0000-0002-3553-0736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Morescalchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006577519","display_name":"Sarah Duse","orcid":"https://orcid.org/0000-0002-7378-6310","observed_orcids":["https://orcid.org/0000-0002-7378-6310"]},"institutions":[{"id":"https://openalex.org/I4210103289","display_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","ror":"https://ror.org/015rhss58","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210103289"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sarah Duse","raw_affiliation_strings":["Ophthalmology Clinic, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia Italy. sarah.duse@alice.it","Ophthalmology Clinic, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology Clinic, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia Italy. sarah.duse@alice.it","institution_ids":["https://openalex.org/I4210103289"]},{"raw_affiliation_string":"Ophthalmology Clinic, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia Italy.,Italy","institution_ids":["https://openalex.org/I4210103289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017489879","display_name":"Elena Gambicorti","orcid":"https://orcid.org/0000-0001-7023-1814","observed_orcids":["https://orcid.org/0000-0001-7023-1814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Gambicorti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085076733","display_name":"Anna Cancarini","orcid":"https://orcid.org/0000-0003-2707-1637","observed_orcids":["https://orcid.org/0000-0003-2707-1637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Cancarini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023102332","display_name":"Ciro Costagliola","orcid":"https://orcid.org/0000-0001-8477-6188","observed_orcids":["https://orcid.org/0000-0001-8477-6188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ciro Costagliola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0584,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.93060028,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"7","first_page":"572","last_page":"584"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegf-inhibitors","display_name":"VEGF inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/subretinal-neovascularization","display_name":"subretinal neovascularization","score":0.9290000200271606},{"id":"https://openalex.org/keywords/ocular-angiogenesis","display_name":"ocular angiogenesis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":0.9440000057220459},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/pegaptanib","display_name":"pegaptanib","score":0.9660000205039978},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/choriocapillaris-atrophy","display_name":"choriocapillaris atrophy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/photoreceptor-degeneration","display_name":"photoreceptor degeneration","score":0.9769999980926514},{"id":"https://openalex.org/keywords/blood-retinal-barrier","display_name":"blood-retinal barrier","score":0.7379999756813049},{"id":"https://openalex.org/keywords/thromboembolic-adverse-events","display_name":"thromboembolic adverse events","score":0.9539999961853027},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.4749999940395355},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9359999895095825},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8043724298477173},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6548828482627869},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.6489492654800415},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5790922045707703},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5711839199066162},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20149677991867065}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005123","descriptor_name":"Eye","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005123","descriptor_name":"Eye","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2174/1389200216666151001120831","doi":"https://doi.org/10.2174/1389200216666151001120831","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389200216666151001120831","pdf_url":null,"source":{"id":"https://openalex.org/S195680726","display_name":"Current Drug Metabolism","issn_l":"1389-2002","issn":["1389-2002","1875-5453"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Metabolism","raw_type":"journal-article"},{"id":"pmid:26424177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26424177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unibs.it:11379/482431","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/482431","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unimol.it:11695/47910","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11695/47910","pdf_url":null,"source":{"id":"https://openalex.org/S7407055127","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi del Molise","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":102,"referenced_works":["https://openalex.org/W172183759","https://openalex.org/W1041957737","https://openalex.org/W1179483079","https://openalex.org/W1481978003","https://openalex.org/W1567760664","https://openalex.org/W1590155607","https://openalex.org/W1591057067","https://openalex.org/W1802218256","https://openalex.org/W1963705625","https://openalex.org/W1964901573","https://openalex.org/W1970410298","https://openalex.org/W1970554379","https://openalex.org/W1972305015","https://openalex.org/W1973281481","https://openalex.org/W1975926216","https://openalex.org/W1976005612","https://openalex.org/W1979172709","https://openalex.org/W1980725734","https://openalex.org/W1984413085","https://openalex.org/W1985314853","https://openalex.org/W1985648029","https://openalex.org/W1985695422","https://openalex.org/W1985712533","https://openalex.org/W1986363023","https://openalex.org/W1988233478","https://openalex.org/W1991311930","https://openalex.org/W1991409385","https://openalex.org/W1992257311","https://openalex.org/W1997000986","https://openalex.org/W1999049852","https://openalex.org/W2002637725","https://openalex.org/W2004117352","https://openalex.org/W2008833866","https://openalex.org/W2009470915","https://openalex.org/W2010800059","https://openalex.org/W2012964196","https://openalex.org/W2019324019","https://openalex.org/W2026216391","https://openalex.org/W2027538443","https://openalex.org/W2033117120","https://openalex.org/W2033245558","https://openalex.org/W2038039729","https://openalex.org/W2039907482","https://openalex.org/W2042661643","https://openalex.org/W2049414526","https://openalex.org/W2049577742","https://openalex.org/W2052892208","https://openalex.org/W2053255808","https://openalex.org/W2059547624","https://openalex.org/W2061563961","https://openalex.org/W2062919998","https://openalex.org/W2064939547","https://openalex.org/W2068230682","https://openalex.org/W2069092801","https://openalex.org/W2069838435","https://openalex.org/W2070924647","https://openalex.org/W2071843728","https://openalex.org/W2077129920","https://openalex.org/W2077203470","https://openalex.org/W2077484263","https://openalex.org/W2079397885","https://openalex.org/W2080000172","https://openalex.org/W2081615960","https://openalex.org/W2083095023","https://openalex.org/W2084101670","https://openalex.org/W2084506573","https://openalex.org/W2085052834","https://openalex.org/W2089498196","https://openalex.org/W2091407629","https://openalex.org/W2091929661","https://openalex.org/W2091989599","https://openalex.org/W2093044616","https://openalex.org/W2096547439","https://openalex.org/W2100864621","https://openalex.org/W2101212248","https://openalex.org/W2102029073","https://openalex.org/W2111502329","https://openalex.org/W2112069706","https://openalex.org/W2114615391","https://openalex.org/W2118548020","https://openalex.org/W2124415048","https://openalex.org/W2131192872","https://openalex.org/W2132849987","https://openalex.org/W2134178766","https://openalex.org/W2135240714","https://openalex.org/W2139037006","https://openalex.org/W2143874967","https://openalex.org/W2145173581","https://openalex.org/W2145224595","https://openalex.org/W2146673937","https://openalex.org/W2154929668","https://openalex.org/W2156113162","https://openalex.org/W2157027608","https://openalex.org/W2159764938","https://openalex.org/W2166185670","https://openalex.org/W2167978843","https://openalex.org/W2171998177","https://openalex.org/W2331755526","https://openalex.org/W2766004112","https://openalex.org/W2915852396","https://openalex.org/W4241964533","https://openalex.org/W4290247175"],"related_works":["https://openalex.org/W3046337220","https://openalex.org/W2126467871","https://openalex.org/W7199362390","https://openalex.org/W2012407775","https://openalex.org/W4385760300","https://openalex.org/W2414258587","https://openalex.org/W2031244057","https://openalex.org/W7163513341","https://openalex.org/W7171788255","https://openalex.org/W2068230682"],"abstract_inverted_index":{"Subretinal":[0],"neovascularization":[1,48],"and":[2,16,43,49,79,125,143,148,181,207,209,216,239],"pathologic":[3],"ocular":[4,45,75,213],"angiogenesis":[5],"are":[6,70,222],"common":[7],"causes":[8,141,202],"of":[9,13,20,32,56,111,123,139,145,150,219,229,234,241,249],"progressive,":[10],"irreversible":[11],"impairment":[12],"central":[14,224],"vision,":[15],"dramatically":[17],"affect":[18],"quality":[19,31],"life.":[21],"Anti-vascular":[22],"endothelial":[23,127],"growth":[24],"factor":[25],"(anti-VEGF)":[26],"therapy":[27,62,94],"has":[28],"improved":[29],"the":[30,54,60,114,121,146,174,178,235,247],"life":[33],"for":[34,84,98,120],"many":[35,99],"patients":[36],"with":[37,157],"age-related":[38],"macular":[39],"degeneration,":[40],"diabetic":[41],"retinopathy,":[42],"other":[44,115],"diseases":[46],"involving":[47],"edema.":[50],"In":[51],"these":[52],"pathologies,":[53],"inhibition":[55,138,164],"intraocular":[57],"VEGF":[58,117,140,163,187],"is":[59,95,118],"only":[61],"that":[63,136,161],"can":[64,89,172],"preserve":[65],"vision.":[66],"Four":[67],"anti-VEGF":[68,170,193,220,242,250],"drugs":[69],"currently":[71],"used":[72,91],"to":[73],"treat":[74],"neovascularization;":[76],"pegaptanib,":[77],"ranibizumab,":[78],"aflibercept":[80],"have":[81,134],"been":[82],"approved":[83],"this":[85,230],"condition,":[86],"while":[87],"bevacizumab":[88],"be":[90],"off-label.":[92],"Anti-VEGF":[93],"administered":[96],"regularly":[97],"months":[100],"or":[101,106],"years":[102],"because":[103],"its":[104],"suspension":[105],"discontinuation":[107],"may":[108],"cause":[109],"recurrence":[110],"neovascularization.":[112],"On":[113],"hand,":[116],"necessary":[119],"survival":[122],"retinal":[124,167],"choroidal":[126],"cells.":[128],"Experimental":[129],"studies":[130,155],"in":[131],"animal":[132],"models":[133],"shown":[135],"local":[137],"thinning":[142],"atrophy":[144],"choriocapillaris":[147],"degeneration":[149],"photoreceptors,":[151],"primarily":[152],"cones.":[153],"These":[154],"combined":[156],"clinical":[158],"experience":[159],"indicated":[160],"prolonged":[162,192],"could":[165,195],"impair":[166],"function.":[168],"Moreover,":[169],"compounds":[171,221,251],"cross":[173],"blood-retina":[175],"barrier,":[176],"enter":[177],"systemic":[179,217],"circulation,":[180],"inhibit":[182],"serum":[183],"VEGF.":[184],"Since":[185],"circulating":[186],"protects":[188],"blood":[189],"vessel":[190],"integrity,":[191],"treatment":[194],"induce":[196],"thromboembolic":[197],"adverse":[198],"events":[199],"from":[200],"vascular":[201],"such":[203],"as":[204],"heart":[205],"attack":[206],"stroke,":[208],"even":[210],"death.":[211],"The":[212],"dosing":[214],"regimen":[215],"toxicity":[218],"therefore":[223],"concerns.":[225],"A":[226],"better":[227],"understanding":[228],"topic":[231],"requires":[232],"knowledge":[233],"metabolism,":[236],"tissue":[237],"distribution,":[238],"clearance":[240],"compounds.":[243],"This":[244],"manuscript":[245],"reviews":[246],"properties":[248],"following":[252],"intravitreal":[253],"administration.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2218436155","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
